MEDICINOVA, INC. Number of Operating Segments
MEDICINOVA, INC. (MNOV) reported Number of Operating Segments of 1 Segment for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Segment Reporting
us-gaap:NumberOfOperatingSegments · last filed 2026-08-13
- MEDICINOVA, INC. number of operating segments for the quarter ending 2026-03-31 was 1.00 Segment, a 0.00% change year-over-year.
- MEDICINOVA, INC. number of operating segments for the quarter ending 2025-03-31 was 1.00 Segment.
- MEDICINOVA, INC. number of operating segments for fiscal 2025 was 1.00 Segment, a 0.00% change from fiscal 2024.
- MEDICINOVA, INC. number of operating segments for fiscal 2024 was 1.00 Segment, a 0.00% change from fiscal 2023.
- MEDICINOVA, INC. number of operating segments for fiscal 2023 was 1.00 Segment, a 0.00% change from fiscal 2022.
- MEDICINOVA, INC. number of operating segments for fiscal 2022 was 1.00 Segment, a 0.00% change from fiscal 2021.
| Period end | Number of Operating Segments 3 month | Number of Operating Segments 6 month | Number of Operating Segments 9 month | Number of Operating Segments 12 month |
|---|---|---|---|---|
| 2026-06-30 | 1.00 Segment 10-Q · filed 2026-08-13 | |||
| 2026-03-31 | 1.00 Segment 10-Q · filed 2026-05-14 | |||
| 2025-12-31 | 1.00 Segment 10-K · filed 2026-03-10 | |||
| 2025-09-30 | 1.00 Segment 10-Q · filed 2025-11-12 | |||
| 2025-06-30 | 1.00 Segment 10-Q · filed 2025-08-14 | |||
| 2025-03-31 | 1.00 Segment 10-Q · filed 2025-05-13 | |||
| 2024-12-31 | 1.00 Segment 10-K · filed 2025-02-19 | |||
| 2023-12-31 | 1.00 Segment 10-K · filed 2024-02-15 | |||
| 2022-12-31 | 1.00 Segment 10-K/A · filed 2023-03-28 | |||
| 2021-12-31 | 1.00 Segment 10-K · filed 2022-02-16 | |||
| 2020-12-31 | 1.00 Segment 10-K · filed 2021-02-19 | |||
| 2019-12-31 | 1.00 Segment 10-K · filed 2020-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |